Johnson and Johnson vaccines resume with cautions. At this time the hospital is NOT able to offer this vaccine.
This message is being sent via the Louisiana Department of Health Emergency Operations Center (LDH EOC) for all Louisiana Health Alert Network (LA HAN) recipients and Primary Care Healthcare Professionals. This message is from LDH regarding the decision by the U.S. Federal Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC) to lift the recommended pause on the Johnson & Johnson (Janssen/J&J) COVID-19 vaccine use following a thorough safety review.
FDA and CDC Lift Recommended Pause on Johnson & Johnson (Janssen/J&J) COVID-19 Vaccine Use Following Thorough Safety Review
Please report any clinically significant thrombotic event or thrombocytopenia in an individual who received the J&J COVID-19 vaccine within the past 6 weeks to the Louisiana Department of Health Infectious Disease Epidemiology Clinician Hotline: 800-256-2748.
Following a thorough safety review, including two meetings of the CDC’s Advisory Committee on Immunization Practices, the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention have determined that the recommended pause regarding the use of the Janssen COVID-19 Vaccine in the U.S. should be lifted and use of the vaccine should resume.